Probisearch attended the Animal Microbiome Congress 2018, 20-21 June, in Paris. The congress welcomed professionals from the pharmaceutical industry as well as public research agencies dedicated to the study and intervention of animal microbiota.
Guest speakers presented and debated the new trends in the area of research and development of probiotics and prebiotics, the regulatory framework and potential for marketing authorization. Also the current market situation was analyzed with current figures and sales forecasts, showing an increasingly receptive market to this new type of products in the fields of production and pets. There was a common concern with antibiotic resistance and how the use of probiotics is a real, effective, safe alternative included in the One Health concept championed by the European Union.
PROBISEARCH is a leader in probiotics research in the area of Animal Health. PROBISEARCH has assembled a multidisciplinary team with expertise in the development and application of microbiological, immunological, metagenomic, transcriptomic, metabolomic and / or proteomic techniques, who have found scientific evidence on the effectiveness of their strains. Additionally, PROBISEARCH has a track record in the design and development of clinical trials in probiotics in accordance with Good Clinical Practices.